Results
Brooks Laboratories Q2 FY27 Net Profit Surges on Divestment Gain
Brooks Laboratories' Board approved unaudited standalone and consolidated financial results for Q2 and H1 FY27, ending September 30, 2026.
The company recorded an exceptional gain of ₹7,470 lakhs from
